Recall
FDAHealthApril 1, 2026

Wells Pharma of Houston LLC — fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

⚠️ cGMP deviations.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
April 1, 2026

U.S. Nationwide.

What's affected?

Product
fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.
Lot code
011226204250063

Additional details

Lot 011226204250063, Exp Date 05/14/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 50 syringes.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.